GE Launches $250 Million Healthymagination Fund
New equity investment fund to invest in high potential healthcare technology companies
GE announced the formation of the “GE Healthymagination Fund”, a new equity fund that will make investments in highly promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sciences technologies aligned with the strategic objectives of GE’s Healthymagination initiative. The fund will also support healthcare companies developing innovative and unique business models and services.
The formation of the fund is part of GE’s $6 billion Healthymagination initiative, a global commitment to deliver better healthcare to more people at lower cost. The fund will target three broad areas for investment:
- Broad-based Diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents and other technologies for disease diagnosis.
- Healthcare Information Technology, including electronic medical records, clinical information systems, healthcare information exchanges and value-added data services.
- Life Sciences, including tools for research and development in biopharmaceuticals and stem cells, and technologies for manufacturing of biopharmaceuticals and vaccines.
The fund will draw on capabilities from across GE Healthcare, GE Capital and GE Global Research, and will have a global footprint.
Other news from the department business & finance
